MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)

Meeting: 2016 International Congress

Abstract Number: 1798

Keywords: Parkinsonism, Tremors: Treatment

Session Information

Date: Thursday, June 23, 2016

Session Title: Other

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the treatment of movement disorders which presented as a consequence of haemorrhage from midbrain cavernous malformations.

Background: Few cases of movement disorders which presented as a consequence of haemorrhage from cavernous malformations of the brainstem were reported in the literature. We present two patients with a haemorrhage from midbrain cavernous malformations which were treated by surgical resection. Both patients developed movement disorders about a month after surgery and were successfully treated with medications.

Methods: Patient T. suffered a haemorrhage from tectal cavernous malformation and presented with occlusive hydrocephalus (GCS 12 an admission). Ventriculo-peritoneal shunting was performed and cavernoma was removed via supracerebellar infratentorial approach in the subacute phase of the haemorrhage. 23 days after surgery patient developed hemidystonia and parkinsonism symptoms. Patient H. had a haemorrhage from cavernous malformation of right cerebral peduncle. He presented with left-sided hemiplegia and right-sided oculomotor palsy. Cavernoma was removed completely via right pterional transsylvian approach , . He was discharged with the regression of hemiparesis (3/5). 34 days after surgery patient developed tremor in left upper extremity (Holmes tremor).

Results: Patient T. (follow-up 4 years) was treated with pramipexole, levodopa, amantadine, clonazepam and levitiracetam. Currently he is symptom-free and receives amantadine 50 mg/day, clonazepame 0.375 mg/day and levitiracetam 500 mg/day. Patient H. (follow-up 3.5 years) received levodopa treatment and his tremor is currently improved more than 50% from the baseline.

Conclusions: Our long-term follow-up on conservative treatment of this rare entity (development of movement disorders after surgical treatment of midbrain cavernous malformations) confirms that it is highly effective.

To cite this abstract in AMA style:

A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv. Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/successful-treatment-of-movement-disorders-after-resection-of-midbrain-cavernous-malformations-report-of-two-cases/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/successful-treatment-of-movement-disorders-after-resection-of-midbrain-cavernous-malformations-report-of-two-cases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley